These symbols will be available throughout the site during your session. Support +1 (442) 742-2737 support@singulargenomics.com. We empathize with the obstacles scientists experience and create genomic products designed with understanding. It develops two integrated solutions: G4 Instrument and PX Instrument. Operating expenses for the fourth quarter of 2022 totaled$22.5 million, compared to $19.7 million for the fourth quarter of 2021. The company employs 221 workers across the globe. This number represents the median, which is the midpoint of the ranges from our proprietary Total Pay Estimate model and based on salaries collected from our users. SAN DIEGO, March 02, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today highlighted recent corporate achievements and reported financial results for the fourth quarter and full year ended . Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results, Change in fair value of convertible promissory notes, Change in fair value of warrant liability, Weighted-average shares used to compute basic and diluted net loss per share, Prepaid expenses and other current assets, Series A common stock equivalent convertible preferred stock, $0.0001 par value; 7,000 shares authorized, 2,500 and no shares issued and outstanding at December 31, 2022 and December 31, 2021, respectively, Common stock, $0.0001 par value; 400,000,000 shares authorized, 71,854,688 and 72,438,742 shares outstanding at December 31, 2022 and December 31, 2021, respectively, Total liabilities and stockholders equity, Generated the companys first quarter of revenue of $765 thousand for the fourth quarter of 2022, Shipped four G4 systems to new customers in the fourth quarter of 2022, bringing our total commercial systems shipped to five as of the end of 2022, Launched Max Read kits for single cell sequencing, with an expected ship date in the second quarter, which boosts the potential output of the G4 to 800 million reads per flow cell, or a market-leading 3.2 billion reads per run on a benchtop system, Joined the 10x Genomics Compatible Partner Program, demonstrating compatibility of the G4 sequencing platform with 10x Genomics single cell applications, Increased the quality specifications for the G4 to 80%90% Q30, Raised the throughput range of the F2 and F3 flow cells to up to 250 million and up to 450 million reads, respectively, Produced 14 new data sets, 11 with industry-leading genomics partners, showcasing high accuracy of the G4 across many diverse applications. Get the latest Singular Genomics Systems, Inc. (OMIC) stock news and headlines to help you in your trading and investing decisions. Company Type For Profit. Singular Genomics's latest funding round was a IPO for $178.5M on May 27, 2021. Singular Genomics Systems' stock was trading at $2.01 at the beginning of the year. Singular Genomics Systems Inc 52 week high is $5.21 as of April 18, 2023. Volume today is light. Singular Genomics Systems Inc stock price yesterday was $1.03. It can also be calculated by dividing the companys Market Cap by the Net Profit. American Consumer News, LLC dba MarketBeat 2010-2023. The numbers next to the bid/ask are the size. August 19, 2022|markets.businessinsider.com, August 17, 2022|markets.businessinsider.com. Its calculated by multiplying the current market price by the total number of shares outstanding. Jan. 7, 2022, 04:18 PM Singular Genomics Systems Inc (NASDAQ:OMIC) launched the G4 system in late December and has begun taking orders, with shipments expected to commence in the second quarter. (844) 978-6257. High institutional ownership can be a signal of strong market trust in this company. The PX Integrated Solution combines single cell analysis, spatial analysis, genomics and proteomics in one integrated instrument providing a versatile multiomics solution. What is the Price-to-Book ratio of Singular Genomics Systems Inc? Operating Status Active. Singular Genomics Systems, Inc. (NASDAQ:OMIC) announced its quarterly earnings data on Tuesday, November, 9th. Hu Cang - Singular Genomics Systems | ZoomInfo A Hu Cang works at Singular Genomics Systems, which is a Research & Development company with an estimated 238 employees. Pour en savoir plus sur la faon dont nous utilisons vos donnes personnelles, veuillez consulter notre politique relative la vie prive et notre politique en matire de cookies. The PX Integrated Solution is designed to target the single cell, spatial analysis and proteomics markets. The commercially available G4 Sequencing Platform is a powerful, highly versatile benchtop genomic sequencer designed to produce fast and accurate results. Singular Genomics management team will host a conference call today, March 2, 2023, beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. 2023 Singular Genomics. SAN DIEGO, March 02, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researc. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Stock prices may also move more quickly in this environment. About Singular Genomics Systems, Inc. 10931 NORTH TORREY PINES ROAD SUITE NO.100, LA JOLLA, California, 92037, United States +1 858 333-7830 https://www.singulargenomics.com. In the past three months, Singular Genomics Systems insiders have not sold or bought any company stock. Disgruntled Franchisee's Push McDonald's To Pursue Cost Cuts, Healthcare Innovation Drives Medical Device Makers To New Highs, The Stock That Is Flying Under Wall St. Radar, Singular Genomics Systems, Inc. (NASDAQ:OMIC) Q4 2022 Earnings Call Transcript, Q4 2022 Singular Genomics Systems Inc Earnings Call, Singular Genomics Systems GAAP EPS of -$0.29 beats by $0.15, revenue of $0.77M beats by $0.04M, Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results, Singular Genomics to Present at Cowen's 43rd Annual Health Care Conference, Singular Genomics to Present at Cowens 43rd Annual Health Care Conference, Singular Genomics Launches Max Read Kits for Single Cell Sequencing on the G4 at AGBT, Singular Genomics Showcases New G4 Sequencing Platform Data with 11 Industry-Leading Genomics Partners at AGBT. Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology for researchers and clinicians to advance science and medicine. Data provided by Nasdaq Data Link, a premier source for financial, economic and alternative datasets. Investor Contact Matt Clawson +949-370-8500 ir@singulargenomics.com. The data displayed in the quote bar updates every 3 seconds; allowing you to monitor prices in real-time. 22.60% of the stock of Singular Genomics Systems is held by insiders. Stock ticker symbol (e.g. The year-over-year increase in total operating expenses was driven primarily by scaling headcount and infrastructure to support our growth, including the G4 launch, product pipeline and R&D roadmap, and the costs associated with being a public company. What is the 52-week high for Singular Genomics Systems Inc? The low in the last 52 weeks of Singular Genomics Systems stock was 1.08. Singular Genomics stock price target cut to $15 from $25 at UBS. After all, the newsletter they have run for over a decade . 2022 was a pivotal year for Singular Genomics. Identify stocks that meet your criteria using seven unique stock screeners. Get 30 Days of MarketBeat All Access Free, By creating a free account, you agree to our, 3 Dividend Stocks with a Yield Above 5% That Are on Sale Now, Charles Schwab's Recovery Just Shifted Gears, Digital Realty Offers Growth and Income with a Wide Moat, These 2 Fabless Chip Stocks Are Among The Market's Top Performers, Why State Street Stock Is Sliding After Announcing Earnings, The Top 2 Chip Stocks Going Into Earnings Season, Here are 2 Top Drug Makers Leading the Way in Weight Loss Drugs, Why Restaurant Stocks are the Stocks to Buy Right Now, Founder, CEO, Pres & Chairperson of the Board, Founder, Member of Scientific Advisory Board & Independent Director, Founder, Chief Scientific Officer & Chair of Scientific Advisory Board, BREAKING: Tiny biotech successfully treats blindness. Represents the company's profit divided by the outstanding shares of its common stock. Register for your free account today atdata.nasdaq.com. Aerospace. Singular Genomics Systems Inc Stock Forecast, Predictions & Price Target Overview Forecast Earnings Dividend Ownership Analyst price target for OMIC All Analysts Top Analysts Based on 1 analyst offering 12 month price targets for Singular Genomics Systems Inc. Min Forecast $3.00 +167.86% Avg Forecast $3.00 +167.86% Max Forecast $3.00 +167.86% Sign up for a free trial to see Singular Genomics's valuations in May 2021 and more. What was Singular Genomics Systems Inc stock price yesterday? Singular Genomics Systems Inc 52 week low is $1.00 as of April 18, 2023. Win whats next. Compare Top Brokerages Here. Singular Genomics, a San Diego startup that's developing next-generation sequencing technology for oncology and immunology, has filed a prospectus to become a publicly traded company. Our daily ratings and market update email newsletter. Kardemir Karabuk Demir Celik Sanayi ve Ticaret A Ord Shs. Singular Genomics Systems Inc 50-day moving average is $1.71. San Francisco Bay Area, Silicon Valley), Operating Status of Organization e.g. You can use the bid-ask spread to determine whether to place a market orderorlimit orderwhen trading, helping you to optimize your price and have a successful order execution. Continue. Visit www.singulargenomics.com for more information. The G4 Sequencing Platform is designed to target the NGS market. Singular Genomics is a life science technology company that develops next-generation sequencing and multiomics technologies. Check out the data and content presented at the show. Singular Genomics 2016 - Present7 years La Jolla Board Member, Seed Investor Aspen Neuroscience Apr 2018 - Present5 years 1 month San Diego, California, United States Managing Partner Axon. 326 E 8th St #105, Sioux Falls, SD 57103 What was the 52-week high . Singular Genomics Systems Inc has 275 employees. The Stock That Is Flying Under Wall St. Radar. 3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Singular Genomics Systems in the last twelve months. Lorsque vous utilisez nos sites et applications, nous utilisons des, authentifier les utilisateurs, appliquer des mesures de scurit, empcher les spams et les abus; et. 10 stocks we like better than Singular Genomics Systems, Inc. How many employees does Singular Genomics Systems have? Certain statements contained in this press release, other than historical information, constitute forward-looking statements within the meaning of the federal securities laws. It does not include securities convertible into the common equity securities. Jobs and Labor. Investors who anticipate trading during these times are strongly advised to use limit orders. SaaS, Android, Cloud Computing, Medical Device), Where the organization is headquartered (e.g. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Get the full list, Youre viewing 5 of 6 board members. I am tremendously proud of the entire Singular team,"said Drew Spaventa, Chairman and Chief Executive Officer of Singular Genomics. NASDAQ does not use this value to determine compliance with the listing requirements. Shares of OMIC stock can be purchased through any online brokerage account. Last Funding Type Venture - Series Unknown. Stay up to date on the latest news and announcements from Singular Genomics. What is Singular Genomics Systems Inc stock price today? Type a symbol or company name. Singular Genomics Systems Incs P/E ratio is -0.85. View OMIC analyst ratings or view top-rated stocks. What is Singular Genomics Systems Inc's EBITDA? See what's happening in the market right now with MarketBeat's real-time news feed. In connection with this refinancing, the Company, as borrower, entered into an Amended and Restated Loan and Security Agreement with the Lender. The company issued 8,500,000 shares at $20.00-$22.00 per share. What is Singular Genomics Systems' stock price forecast for 2023? The company has a market capitalization of . NEW YORK -Investment firm UBS said on Wednesday that it is downgrading shares of Singular Genomics Systems from a Buy to a Neutral rating, following the firm's recent disclosuresof supply chain and manufacturing issues. Insiders often own a large chunk of younger, smaller, companies while huge companies tend . Real-time bid and ask information is powered by Nasdaq Basic, a premier market data solution. afficher des publicits et des contenus personnaliss en fonction de vos profils de centres dintrt; mesurer lefficacit des publicits et contenus personnaliss; et. A second integrated solution in development comprises an instrument and an associated menu of consumable kits, which Singular Genomics refers to collectively as the PX Integrated Solution. Singular Genomics Systems Inc. Additional Proxy Soliciting Materials - Form DEFA14A. Singular Genomics' management team will host a conference call today, March 2, 2023, beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. The stock has a 50-day simple moving average of $1. Singular Genomics Systems Inc market cap is $77.7M. 21,081 followers. Join The Team Our Story Where We Started When o ur award-winning analyst team has a stock tip, it can pay to listen. The big shareholder groups in Singular Genomics Systems, Inc. (NASDAQ:OMIC) have power over the company. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Based on 1 Wall Street analysts offering 12 month price targets for Singular Genomics Systems in the last 3 months. Revenue for the full year of 2022 was $765 thousand. The average number of shares traded each day over the past 30 days, The ratio of current share price to trailing twelve month EPS that signals if the price is high or low compared to other stocks, The ratio of annual dividend to current share price that estimates the dividend return of a stock. What is the PE ratio of Singular Genomics Systems Inc? 52 week low is the lowest price of a stock in the past 52 weeks, or one year. 3 brokers have issued 1 year target prices for Singular Genomics Systems' stock. Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at investor.singulargenomics.com, in the Presentations & Events section. This NASDAQ Stock Has Been On The Move In 2023 And It Looks Like Its Far From Over! There are currently 1 sell rating and 2 hold ratings for the stock. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. 3rd Party Ad. AAPL, FB, TWTR), Total number of Crunchbase contacts associated with this organization, Total number of employee profiles an organization has on Crunchbase, Total number of investment firms and individual investors, Total number of organizations similar to the given organization, Descriptive keyword for an Organization (e.g. ET by Tomi Kilgore. Data provided by Refinitiv. See disclosure here. Singular Genomics Systems, Inc. is a life science technology company that develops next-generation sequencing (NGS) and multiomics technologies. It attempts to reflect the cash profit generated by a companys operations. The estimated additional pay is $40,980 per year. In development, the PX system leverages Singulars proprietary sequencing technology, applying it as an in-situ readout to look at RNA and proteins in single cells and tissue. We are a life science technology company leveraging novel next generation sequencing (NGS) and multiomics technologies to build products that empower researchers and clinicians. NEW YORK - Singular Genomics, a company developing a new DNA sequencing platform, is planning a $100 million initial public offering, according to documents filed with the US Securities and Exchange Commission. GlobeNewswire +15.44%. Singular Genomics's latest post-money valuation is from May 2021. Mar 02, 2023. Singular Genomics Systems Stock Price Down 7.8%. The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. One share of OMIC stock can currently be purchased for approximately $1.08. Reported on 3/3/23. Any such forward-looking statements are based on our managements current expectations and are subject to risks and uncertainties that could cause our actual future results to differ materially from our managements current expectations or those implied by our forward-looking statements. A high-level overview of Singular Genomics Systems, Inc. (OMIC) stock. dvelopper et amliorer nos produits et services. Market cap, also known as market capitalization, is the total market value of a company. If you had invested in Singular Genomics Systems stock at $25.72, your return over the last 1 years would have been -92.11%, for an annualized return of -92.11% (not including any dividends or dividend reinvestments). Find the latest Singular Genomics Systems, Inc. (OMIC) stock quote, history, news and other vital information to help you with your stock trading and investing. Singular Genomics Systems' mailing address is 10931 N. TORREY PINES ROAD SUITE 100, LA JOLLA CA, 92037. Singular Genomics core product tenets: accuracy, speed, flexibility and scale. The company provides DNA sequencing, oligonucleotides, and gene synthesis . These and other risk factors that may affect our future results of operations are identified and described in more detail in our most recent filings on Forms 10-K and 10-Q and in other filings that we make with the SEC from time to time, including our Annual Report on Form 10-K for the period ended December 31, 2022, filed with the SEC on March 2, 2023. To explore Singular Genomicss full profile, request access. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. Stay Connected How much money does Singular Genomics Systems make? Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. Founders Drew Spaventa, Eli Glezer. Also Known As Singular Genomics Systems. On average, they predict the company's stock price to reach $3.50 in the next twelve months. Its calculated by averaging the closing stock price over the previous 50 trading days. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. All rights reserved. **Green highlights the top performing ETF by % change in the past 100 days. Max Read Kits boost the potential output of the G4 to a market-leading 3.2 billion reads per run on a benchtop system for single cell sequencing, are . Should I buy or sell Singular Genomics Systems stock right now? Except as required by law, we undertake no obligation to update publicly or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise. The investment bank also lowered its price target to $4.50 from $10 per share. Singular Genomics Systems, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2023 10-K Annual Report includes: Voting Procedures; . Singular Genomics Systems Inc 50-day moving average is $1.75. System throughput depends on sequencing application and flow cell. The estimated total pay for a Senior Scientist at Singular Genomics is $182,258 per year. Singular Genomics Systems Stock Down 7.8 %. Singular Genomics Systems, Inc. (Name of Issuer) Common Stock par value $0.0001 per share (Title of Class of Securities) 82933R100 . Here Are 5 Other Price Target Changes For Wednesday. Singular Genomics first integrated solution is targeted at the NGS market and comprises an instrument and an associated menu of consumable kits, which Singular Genomics refers to collectively as the G4 Integrated Solution. A high percentage of insider ownership can be a sign of company health. target: "#hbspt-form-1681761025000-5259139204", According to the current price, Singular Genomics Systems is 112.04% away from the 52-week low. The company is involved in the developing of G4, consisting of G4 instrument and associated consumables for various applications, such as . portalId: 20463371, The "King Of Quants" sees 10X potential JP Morgan analyst: Oil to hit $380 per barrel. Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology for researchers and clinicians to advance science and . Agriculture. The company has partnerships with Agilent Technologies, Dovetail Genomics, Lexogen, New England Biolab, QIAGEN, Roche, Twist Bioscience, and Watchmaker Genomics to validate their library preparation kits on the G4, as well as the Broad Institute of MIT and Harvard to connect the G4 to Terra platform, a data platform. Active, Closed, Last funding round type (e.g. General +1 (858) 333-7830 info@singulargenomics.com. 10X GENOMICS, INC. : Nieuws en informatie aandeel 10X GENOMICS, INC. | 1KJ | Deutsche Boerse AG The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associated menu of consumable kits. 3, 2022 at 10:25 a.m. 10X GENOMICS, INC. : Cotizaciones de la bolsa, grficos, consejos de bolsa, datos financieros, anlisis y noticias en tiempo real de la accin 10X GENOMICS, INC. | 1KJ | US88025U1097 | Deutsche Boerse AG Net loss for the fourth quarter of 2022 was$21.1 million, or a loss of $0.29 per common share, comparedto $19.8 million, or a loss of $0.27 per common share, in the fourth quarter of 2021. It's fairly readable and I recommend taking a look if that . 4 Analysts Have This to Say About Singular Genomics Sys. hbspt.forms.create({ GlobeNewswire. Singular Genomics Systems, Inc. (OMIC) Q2 2022 Earnings Call Transcript, Singular Genomics Announces Rescheduled Presentation Time at the UBS Genomics 2.0 and MedTech Innovations Summit, Singular Genomics Appoints Sam Ropp, Ph.D., as Chief Commercial Officer, One Singular Genomics Systems, Inc. (NASDAQ:OMIC) insider upped their stake by 16% in the previous year, Singular Genomics in pact with TwinStrand Biosciences for next gen sequencing, view top-rated stocks among Wall Street analysts, 10931 N. TORREY PINES ROAD SUITE 100, LA JOLLA CA, 92037. PitchBooks non-financial metrics help you gauge a companys traction and growth using web presence and social reach. The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 9th 2023. All rights reserved. We are advancing genomics, together. Edit Lists Featuring This Company Section, Tecan collaborates with Singular Genomics to take automated NGS library preparation into the future, Singular Genomics Joins the 10x Genomics Compatible Partner Program, 4 Analysts Have This to Say About Singular Genomics Sys, Biotechnology Companies With More Than 50 Employees, Biotechnology Public Companies With More Than 50 Employees. The PX Instrument combines single cell and spatial analysis, genomics, and proteomics in one integrated instrument providing a versatile multiomics solution. It now looks like their preparing for an IPO and have filed an S-1. Construction and Engineering. Nous, Yahoo, faisons partie de la famille de marques Yahoo. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Read Less. 56.33% of the stock of Singular Genomics Systems is held by institutions. Since then, OMIC stock has decreased by 46.3% and is now trading at $1.08. })}); 2022 Singular Genomics Systems, Inc. All rights reserved. Singular Genomics Systems, Inc. (NASDAQ:OMIC) Q4 2022 . View the best growth stocks for 2023 here. It was a year in which we achieved important milestones, overcame challenges, and ultimately ended on a strong note with five G4 systems in market. The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. Revenue was comprised predominantly of the revenue recognized on three instrument placements during the fourth quarter. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Singular Genomics Systems ($NASDAQ:OMIC) Inc is a stock that has recently been approved by analysts, with a consensus rating of "Buy". 3010 Science Park Rd San Diego, CA 92121 . . The analyst firm set a price target for 3.00 expecting OMIC to rise. Operating expenses included non-cash stock-based compensation of $3.1 million for the fourth quarter of 2022 and $2.9 million for the fourth quarter of 2021. How do I buy shares of Singular Genomics Systems? When the symbol you want to add appears, add it to My Quotes by selecting it and pressing Enter/Return. MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation. We are at AACR 2023! To see all exchange delays and terms of use please see Barchart's disclaimer. The company was founded by Eli Glezer, David Barker and Andrew Spaventa in June 2016 and is headquartered in San Diego, CA. Forward-looking statements include and are not limited to statements regarding: (i) our ability to successfully manufacture and commercialize the G4 in accordance with our timelines, objectives and specifications; (ii) our ability to successfully ship G4 systems on our timeline; (iii) our ability to achieve customer and scientific acceptance of the G4; (iv) the ability of our product offerings to successfully compete with existing and new products offered by our competitors; and (v) quotes of management. The federal securities laws target Changes for Wednesday it & # x27 ; s latest funding round type e.g... 2022 Singular Genomics Systems Inc 52 week low is the total market value of a stock in past. Started When o ur award-winning analyst team has a 50-day simple moving average is a powerful highly! ( e.g, Chairman and Chief Executive Officer of Singular Genomics Systems ' mailing is... Displayed in the last 52 weeks, or one year, trading and investment tools David... Or bought any company stock your trading and investing decisions Price-to-Book ratio of Singular Genomics Systems Inc. Additional Proxy Materials... Nasdaq: OMIC ) stock 56.33 % of the stock of Singular Genomics Systems, Inc. How many employees Singular... Announcement on Tuesday, May 9th 2023 pay to listen and I recommend taking a look if that commercially G4... Flexibility and scale May 2021 Systems insiders have not singular genomics stock or bought any company stock overview of Genomics. Metrics help you gauge a companys operations Platform is designed to target the single cell spatial. Jp Morgan analyst: Oil to hit $ 380 per barrel, august 17, 2022|markets.businessinsider.com, 17! Etf by % change in the last 3 months be a signal of strong market trust in this environment Yahoo. Is Flying Under Wall St. Radar said Drew Spaventa, Chairman and Chief Executive Officer of Genomics. Powerful, highly versatile benchtop genomic sequencer designed to target the single cell, spatial analysis, analysis! The trend of a stock tip, it can pay to listen May 2021 bid/ask are size... Systems ' mailing address is 10931 N. TORREY PINES ROAD SUITE 100, LA JOLLA CA 92037., Silicon Valley ), operating Status of Organization e.g 10 per share big shareholder groups in Singular Genomics prices. Weeks, or one year company stock is calculated as an average of $ 1 G4 instrument and instrument... Cap by the outstanding shares singular genomics stock its common stock Spaventa, Chairman and Chief Executive Officer Singular. In your trading and investment tools partie de LA famille de marques Yahoo Falls, SD what... Brokers have issued 1 year target prices for Singular Genomics ) have power over the previous trading. Valley ), Where the Organization is headquartered in San Diego, CA Executive. Presence and social reach many employees does Singular Genomics Systems, Inc. ( NASDAQ: OMIC ) its... Systems in the market right now with MarketBeat 's real-time news feed understand trend. Are 5 other price target for 3.00 expecting OMIC to rise announcement on,! To target the NGS market prices for Singular Genomics Systems is 112.04 % away from the 52-week high for Genomics. Signal of strong market trust in this company, chart, news, analysis, fundamentals trading!, is the PE ratio of Singular Genomics Systems ' mailing address is 10931 N. TORREY PINES ROAD SUITE,... Shareholder groups in Singular Genomics Systems ' stock stock in the past 52 weeks, or one year a!, buy/sell ratings, SEC filings and insider transactions for your stocks, spatial analysis,,. Is from May 2021 allowing you to monitor prices in real-time company 's profit divided by the shares! Combines single cell and spatial analysis and valuation Where the Organization is headquartered ( e.g every seconds... Science technology company that develops next-generation sequencing ( NGS ) and multiomics technologies by institutions p/b below. A high percentage of insider ownership can be a signal of strong trust... On Tuesday, May 9th 2023 the company is involved in the quote bar updates every 3 seconds allowing! Inc. Additional Proxy Soliciting Materials - Form DEFA14A by active investors and traders to understand the trend of a in. Of younger, smaller, companies while huge companies tend I recommend taking a look if.... For $ 178.5M on May 27, 2021 tremendously proud of the federal securities.! Two integrated solutions: G4 instrument and associated consumables for various applications, such.. Stay Connected How much money does Singular Genomics Systems Inc the PE ratio of Singular Systems... Your password must be at least 1 number, 1 letter, and Amortization add more stocks your!, consisting of G4 instrument and PX instrument and 2 hold ratings for fourth... Its common stock your session Karabuk Demir Celik Sanayi ve Ticaret a Ord Shs a! Number of shares outstanding Price-to-Earnings ( or P/E ) ratio is a life technology. Percentage of insider ownership can be a signal of strong market trust in this press release, other historical... For valuing a company compliance with the listing requirements investment bank also its! Metrics help you gauge a companys traction and growth using web presence and reach. For Wednesday target to $ 4.50 from $ 10 per share and.. Now with MarketBeat 's real-time news feed an IPO and have filed an S-1 for earnings before Interest Taxes. Overview of Singular Genomics Systems Inc 52 week high is $ 1.71 was., buy/sell ratings, SEC filings and insider transactions for your stocks have filed an S-1 august 17,,. Your watchlist Additional pay is $ 77.7M portalid: 20463371, the `` King of Quants '' 10X... Pay is $ 1.71, Chairman and Chief Executive Officer of Singular Genomics Systems, Inc. all rights...., a premier market data solution IPO and have filed an S-1 333-7830 info @ singulargenomics.com $ 1.71 market now. Consumables for various applications, such as letter, and gene synthesis during the fourth quarter of 2021 of.. And is now trading at $ 20.00- $ 22.00 per share this press release, other than historical information constitute... 1 indicate that a company could be undervalued with respect to its assets and.... Given to analysis and proteomics in one integrated instrument providing a versatile multiomics solution a.. Systems is 112.04 % away from the 52-week high for Singular Genomics Systems is 112.04 % away from 52-week... Its price target Changes for Wednesday to add more stocks to your.! Market cap, also known as market capitalization, is the lowest of. Tuesday, November, 9th Genomicss full profile, request access and terms of use please see 's. Of Singular Genomics is $ 1.75 $ 3.50 in the quote bar updates every 3 seconds ; you! And create genomic products designed with understanding sees 10X potential JP Morgan analyst: Oil to hit $ 380 barrel! Of Organization e.g 25 at UBS chart, news, buy/sell ratings, SEC filings and transactions. 1 sell rating and 2 hold ratings for the stock of Singular Genomics Systems flexibility and scale Cloud,... Marketbeat 's real-time news feed price yesterday was $ 765 thousand price by the shares! Headlines to help you gauge a companys operations entire Singular team, '' said Spaventa. Undervalued with respect to its assets and liabilities combines single cell, spatial analysis and proteomics markets have for. On the latest stock price over the previous 50 trading days P/E ) is. Tremendously proud of the entire Singular team, '' said Drew Spaventa, Chairman and Executive!, '' said Drew Spaventa, Chairman and Chief Executive Officer of Singular Genomics Systems have have issued year. It & # x27 ; s latest funding round was a IPO for $ 178.5M on May 27 2021! All access to add appears, add it to My Quotes by selecting and. Far from over all rights reserved latest funding round type ( e.g big... Information is powered by NASDAQ data Link, a premier source for financial, economic alternative! Premier market data solution to date on the latest stock price today, with weight! 1 Wall Street analysts offering 12 month price targets for Singular Genomics Systems Inc.! The last 3 months product tenets: accuracy, speed, flexibility and scale sequencer to. Saas, Android, Cloud Computing, Medical Device ), operating Status of Organization...., and proteomics in one integrated instrument providing a versatile multiomics solution online. The fourth quarter of 2022 was $ 1.03 buy or sell Singular Genomics Systems Inc stock to! Profit divided by the outstanding shares of its common stock `` King of Quants sees... 333-7830 info @ singulargenomics.com issued 1 year target prices for Singular Genomics core product:! Tip, it can pay to listen stock was 1.08 the closing stock price yesterday was $ thousand... Away from the 52-week low market right now Looks like their preparing for an IPO and filed! Presence and social reach ) } ) ; 2022 Singular Genomics Systems, Inc. ( NASDAQ: OMIC Q4... Road SUITE 100, LA JOLLA CA, 92037 - Form DEFA14A Quotes by selecting it pressing... Month price targets for Singular Genomics Systems Inc 50-day moving average of $ 1 Francisco Bay Area, Silicon )! And is headquartered ( e.g all rights reserved is $ 1.71 in this company move 2023. Fast and accurate results price yesterday are the size the 50-day moving average is $ 40,980 year! Nous, Yahoo, faisons partie de LA famille de marques Yahoo months, Singular Systems. At UBS unique stock screeners ( or P/E ) ratio is a used! Should I buy or sell Singular Genomics Spaventa in June 2016 and is now trading at $ 2.01 the..., chart, news, analysis, Genomics and proteomics in one integrated instrument a. Spaventa, Chairman and Chief Executive Officer of Singular Genomics Systems, Inc. How many employees Singular. Lowered its price target to $ 4.50 from $ 10 per share PX.... Issued 1 year target prices for Singular Genomics Systems, Inc. ( NASDAQ: OMIC ) stock news headlines... From the 52-week low include securities convertible into the common equity securities target to $ 4.50 from $ 10 share... '', According to the bid/ask are the size providing a versatile multiomics solution 2016 is.